2'-(5''-phosphoribosyl)-5'-adenosine monophosphate: monomer of polyADP ribose [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
2'-(5-phosphoribosyl)-5'-AMP : An AMP-sugar in which the 2'-hydroxy group of AMP carries a 5-phospho-beta-D-ribosyl substituent. Monomer unit of poly(ADP-Rib) [poly(adenosine diphosphate ribose)]. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 3080702 |
CHEBI ID | 76110 |
MeSH ID | M0066822 |
Synonym |
---|
2'-(5''-phosphoribosyl)-5'-adenosine monophosphate |
ribosyladenosine 5',5''-bis(phosphate) |
5'-adenylic acid, 2'-o-(5-o-phosphono-beta-d-ribofuranosyl)- |
15720-01-1 |
2-(5''-phosphoribosyl)-5'-amp |
[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-4-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]oxy-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate |
2'-(5''-phosphoribosyl)adenosine 5'-monophosphate |
2'-(1''-ribosyl)adenosine 5',5''-bis(phosphate) |
EPITOPE ID:191108 |
2'-o-(5-o-phosphono-beta-d-ribofuranosyl)adenosine 5'-(dihydrogen phosphate) |
ado(p)-rib-p |
2'-(5-phosphoribosyl)adenosine 5'-monophosphate |
o(2')-(o(5')-phosphono-beta-d-ribofuranosyl)-[5']adenylic acid |
2'-(5-phosphoribosyl)-5'-amp |
2'-o-(5-o-phosphono-beta-d-ribofuranosyl)-5'-adenylic acid |
2'-(1-ribosyl)adenosine 5',5-bis(phosphate) |
CHEBI:76110 , |
DTXSID50166226 |
2/'-(5/'/'-phosphoribosyl)-5/'-adenosine monophosphate |
2'-o-[(5'-phospho)ribosyl]adenosine-5'-monophosphate |
Q27145757 |
iso-adp-ribose |
Class | Description |
---|---|
AMP-sugar | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.60) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |